## **Core Concept**
Pubey menorrhagia, also known as dysfunctional uterine bleeding (DUB) or abnormal uterine bleeding (AUB), is a common condition in adolescents characterized by excessive menstrual bleeding. It is primarily related to **anovulatory cycles**, where the lack of ovulation leads to unopposed estrogen production, causing endometrial proliferation and subsequent heavy bleeding.

## **Why the Correct Answer is Right**
The correct approach to treating pubey menorrhagia often involves hormonal therapy to regulate menstrual cycles and reduce bleeding. **Tranexamic acid** is an antifibrinolytic agent that can effectively reduce menstrual blood loss by inhibiting the breakdown of fibrin clots. It works by blocking the lysine-binding sites on plasminogen, preventing plasmin formation, and thus stabilizing fibrin clots from degradation. This mechanism makes tranexamic acid particularly useful for managing heavy menstrual bleeding.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While NSAIDs can be used to treat dysmenorrhea and may help reduce menstrual flow, they are not typically the first-line treatment for menorrhagia and do not address the underlying hormonal imbalance or anovulatory cycles.
- **Option B:** Although combined oral contraceptives (COCs) can regulate menstrual cycles and reduce bleeding, they might not be immediately prescribed to adolescents due to potential side effects, the need for daily adherence, and concerns about long-term use in young patients.
- **Option D:** While surgical options like dilation and curettage (D&C) may be considered in some cases of menorrhagia, they are generally reserved for when medical management fails or in cases of suspected endometrial hyperplasia or cancer, not as a first-line treatment for pubey menorrhagia.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **tranexamic acid** is a highly effective, non-hormonal treatment option for managing heavy menstrual bleeding, including pubey menorrhagia. It is particularly useful for patients who cannot or do not want to use hormonal therapies. Its efficacy in reducing menstrual blood loss has been well-documented in clinical trials.

## **Correct Answer:** . Tranexamic acid